AA
IMGN

AlphaCentric Advisors’s Immunogen Inc IMGN Stock Holding History

AlphaCentric Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-127,500
Closed -$3.78M – 254
2023
Q4 		$3.78M Buy
127,500
+65,000
+104% +$1.29M 2.54% 7
2023
Q3 		$992K Buy
+62,500
New +$1.04M 0.56% 62

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AlphaCentric Advisors's IMGN Position: Q1 2024 in Review

AlphaCentric Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 127,500 shares — an estimated $3.78M sold.

AlphaCentric Advisors first reported a position in IMGN in Q3 2023 and held it in 2 quarters. The position peaked at $3.78M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • AlphaCentric Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • AlphaCentric Advisors sold 127,500 Immunogen Inc shares in Q1 2024, an estimated $3.78M.
  • AlphaCentric Advisors first reported a position in Immunogen Inc in Q3 2023 and held it in 2 quarters.
  • AlphaCentric Advisors's Immunogen Inc position peaked at $3.78M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on AlphaCentric Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.